DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ogata K, Mendell-Harary J, Tachibana M , et al.
Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers.
J Clin Pharmacol 2010;
50 (7) 743-753
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.